SCHEMBL9997286

SCHEMBL9997286

CCC(=Cc1cccc(Br)c1)C(OC(C)=O)OC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A19 Q695T7 1/20 0.47
ALDH1A1 P00352 2/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B3 P37058 1/20 0.42
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
PKM P14618 1/20 0.39
GAA P10253 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
BACE1 P56817 1/20 0.38
MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997512 1.00 SLC6A19 (0.47) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9997568 0.89 SLC6A19 (0.45) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9997570 0.89 SLC6A19 (0.45) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9997905 0.84 LMNA (0.41) ALDH1A1MAPTPKMGAAMEN1
SCHEMBL9997881 0.84 LMNA (0.41) ALDH1A1MAPTPKMGAAMEN1
SCHEMBL9998294 0.84 ALDH1A1 (0.42) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9997590 0.84 ALDH1A1 (0.42) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9998197 0.84 HSD17B3 (0.45) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9998196 0.84 HSD17B3 (0.45) SLC6A19ALDH1A1HTTMAPTNPSR1
SCHEMBL9997644 0.83 PPARG (0.37) ALDH1A1HTTMAPTNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 SLC6A19 1360/4885ALDH1A1 160/4885HTT 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.